An observational study in Head and Neck Cancer and Tobacco Use Disorder, sponsored by M.D. Anderson Cancer Center. Status unknown. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-11-08.
Sponsored by M.D. Anderson Cancer Center · Observational
RATIONALE: A counseling program that motivates patients to stop smoking and drinking may reduce the risk of oral cancer. It is not yet known whether motivational stop smoking counseling or motivational stop-smoking and stop drinking counseling is more effective in helping patients stop smoking and drinking.
PURPOSE: This randomized clinical trial is studying how well treatment to stop smoking and drinking works in preventing oral cancer in smokers in Puerto Rico.
OBJECTIVES:
OUTLINE: Minimization randomization is applied using the following variables: age, gender, cigarettes/day, number of drinks/day, and depression (score on the Center of Epidemiologic Studies Depression Scale). Patients are randomized to 1 of 2 intervention arms.
In both arms, patients receive counseling calls over 15-30 minutes the week before quit date (QD), on QD, 3-5 days after QD, 7-10 days after QD, 15-30 days after QD, 45-60 days after QD, and on day 90 after QD. Patients complete questionnaires for alcohol- and smoking-related measures, self efficacy, stress/negative affects/depression, social support, and physical activity at baseline and weeks 12, 26 and 52 after QD.
968 studies on the registry are indexed under Tobacco Use Disorder; 126 are open to participants now.
This study's planned enrollment of 370 is above the median of 128 across 74 observational studies indexed under Tobacco Use Disorder.
Browse Tobacco Use Disorder studies →M.D. Anderson Cancer Center is the lead sponsor of 2,999 studies on the registry; 581 are open to participants now.
Of its 599 completed or terminated interventional studies of FDA-regulated products, 402 (67%) have results posted.
Counted across the registry records on this site, refreshed daily.
Adult Smokers Residing in Puerto Rico
DISEASE CHARACTERISTICS:
Exhibits at least one of the following criteria for at-risk drinking:
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
MAPS+ (Motivation and Problem-Solving Plus): Counseling using specific treatment approach that focuses on combined smoking cessation and the reduction of at-risk alcohol use.
Behavioral: smoking cessation intervention · Other: counseling intervention · Other: preventive intervention · Other: questionnaire administration
MAPS (Motivation and Problem-Solving): Counseling treatment approach with a focus on smoking cessation.
Behavioral: smoking cessation intervention · Other: questionnaire administration
Standard quit-smoking counseling to help decrease their risk of cancer.
Counseling focusing on decreasing risk of getting cancer by decreasing smoking and alcohol use.
Also known as: survey
Participant At-risk drinking status
Time frame: 52 weeks
Smoking cessation
Time frame: 52 weeks
No study locations are listed for this record.
This study is status unknown, as verified in Nov 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
M.D. Anderson Cancer Center